Phadke Daniel, Beller Jared P, Tribble Curt
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia, USA.
Heart Surg Forum. 2018 Dec 19;21(6):E522-E526. doi: 10.1532/hsf.2008.
Hyperglycemia is a metabolic derangement that frequently develops after cardiovascular surgery. The perioperative administration of inotropic and vasoactive agents, such as epinephrine and norepinephrine, are common in the management of cardiac surgery patients and are known to contribute to the development of postoperative hyperglycemia. We hypothesized that hemodynamic support with epinephrine exacerbates postoperative hyperglycemia to a greater degree than does treatment with norepinephrine. This literature review outlines the mechanisms by which epinephrine and norepinephrine alter glucose homeostasis, while highlighting the significant differences in their effects on hepatic glucose mobilization and peripheral glucose utilization. This review suggests that the use of epinephrine exacerbates postoperative hyperglycemia to a greater degree than does norepinephrine.
高血糖是一种代谢紊乱,常在心血管手术后出现。围手术期使用诸如肾上腺素和去甲肾上腺素等强心剂和血管活性药物在心脏手术患者的管理中很常见,并且已知会导致术后高血糖的发生。我们假设,与去甲肾上腺素治疗相比,使用肾上腺素进行血流动力学支持会在更大程度上加剧术后高血糖。这篇文献综述概述了肾上腺素和去甲肾上腺素改变葡萄糖稳态的机制,同时强调了它们对肝脏葡萄糖动员和外周葡萄糖利用影响的显著差异。这篇综述表明,与去甲肾上腺素相比,使用肾上腺素会在更大程度上加剧术后高血糖。